Related references
Note: Only part of the references are listed.Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease
Sofia Fernandez-de Retana et al.
NEUROBIOLOGY OF AGING (2017)
Role of clusterin in the brain vascular clearance of amyloid-β
Amy R. Nelson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update
Karim Farid et al.
NEUROIMAGE-CLINICAL (2017)
Reconstituted high-density lipoproteins acutely reduce soluble brain Aβ levels in symptomatic APP/PS1 mice
Jerome Robert et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Modulation of Amyloid-β1-40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier
Cristina Merino-Zamorano et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Evaluation of reconstituted high-density lipoprotein (rHDL) as a drug delivery platform - a detailed survey of rHDL particles ranging from biophysical properties to clinical implications
Jens B. Simonsen
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Spectroscopic Characterization of Structural Changes in Membrane Scaffold Proteins Entrapped within Mesoporous Silica Gel Monoliths
Wade F. Zeno et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Increased concentration of clusterin/apolipoprotein J (apoJ) in hyperlipemic serum is paradoxically associated with decreased apoJ content in lipoproteins
Anna Rull et al.
ATHEROSCLEROSIS (2015)
Lack of Widespread BBB Disruption in Alzheimer's Disease Models: Focus on Therapeutic Antibodies
Nga Bien-Ly et al.
NEURON (2015)
Cerebral Amyloid Angiopathy: Emerging Concepts
Masahito Yamada
JOURNAL OF STROKE (2015)
Monitoring the Stability of Perfluorocarbon Nanoemulsions by Cryo-TEM Image Analysis and Dynamic Light Scattering
Christoph Grapentin et al.
PLOS ONE (2015)
Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease
Wesley Jongbloed et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Lipoprotein-Based Nanoparticles Rescue the Memory Loss of Mice with Alzheimer's Disease by Accelerating the Clearance of Amyloid-Beta
Qingxiang Song et al.
ACS NANO (2014)
High-Density Lipoproteins and Cerebrovascular Integrity in Alzheimer's Disease
Sophie Stukas et al.
CELL METABOLISM (2014)
Hot spots in apolipoprotein A-II misfolding and amyloidosis in mice and men
Olga Gursky
FEBS LETTERS (2014)
Combined Effects of Alzheimer Risk Variants in the CLU and ApoE Genes on Ventricular Expansion Patterns in the Elderly
Florence F. Roussotte et al.
JOURNAL OF NEUROSCIENCE (2014)
Clusterin regulates beta-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway
R. Killick et al.
MOLECULAR PSYCHIATRY (2014)
Expression and Purification of Chaperone-Active Recombinant Clusterin
Rebecca A. Dabbs et al.
PLOS ONE (2014)
Associations Between Serum Cholesterol Levels and Cerebral Amyloidosis
Bruce Reed et al.
JAMA NEUROLOGY (2014)
Clusterin Associates Specifically with Aβ40 in Alzheimer's Disease Brain Tissue
David R. Howlett et al.
BRAIN PATHOLOGY (2013)
Type 2 Diabetes as a Risk Factor for Alzheimer's Disease: The Confounders, Interactions, and Neuropathology Associated With This Relationship
Nicholas T. Vagelatos et al.
EPIDEMIOLOGIC REVIEWS (2013)
Thematic Review Series: High Density Lipoprotein Structure, Function, and Metabolism Unraveling the complexities of the HDL lipidome
Anatol Kontush et al.
JOURNAL OF LIPID RESEARCH (2013)
Thematic Review Series: High Density Lipoprotein Structure, Function, and Metabolism Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond
Amy S. Shah et al.
JOURNAL OF LIPID RESEARCH (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Cerebral Atherosclerosis Is Associated With Cystic Infarcts and Microinfarcts but Not Alzheimer Pathologic Changes
Ling Zheng et al.
STROKE (2013)
Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias
Mark Yarchoan et al.
BRAIN (2012)
Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk
I-Fang Ling et al.
PLOS ONE (2012)
Reconstituted Lipoprotein: A Versatile Class of Biologically-Inspired Nanostructures
Daniel A. Bricarello et al.
ACS NANO (2011)
Plasma Clusterin and the Risk of Alzheimer Disease
Elisabeth M. C. Schrijvers et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Biological activities of HDL subpopulations and their relevance to cardiovascular disease
Laurent Camont et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Near infrared planar tumor imaging and quantification using nanosized Alexa 750-labeled phospholipid micelles
Aristarchos Papagiannaros et al.
International Journal of Nanomedicine (2010)
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease LEADe
H. H. Feldman et al.
NEUROLOGY (2010)
Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model
Kalliopi Thanopoulou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Classification and basic pathology of Alzheimer disease
Charles Duyckaerts et al.
ACTA NEUROPATHOLOGICA (2009)
Alzheimer's disease drug development and the problem of the blood-brain barrier
William A. Pardridge
ALZHEIMERS & DEMENTIA (2009)
Clusterin: A forgotten player in Alzheimer's disease
Tapio Nuutinen et al.
BRAIN RESEARCH REVIEWS (2009)
Midlife Serum Cholesterol and Increased Risk of Alzheimer's and Vascular Dementia Three Decades Later
Alina Solomon et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier
David D. Stenehjem et al.
FUTURE MEDICINAL CHEMISTRY (2009)
HDL is the major lipoprotein carrier of plasma F2-isoprostanes
Julie M. Proudfoot et al.
JOURNAL OF LIPID RESEARCH (2009)
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2009)
Apolipoprotein AI tertiary structures determine stability and phospholipid-binding activity of discoidal high-density lipoprotein particles of different sizes
Bin Chen et al.
PROTEIN SCIENCE (2009)
Cerebral amyloid angiopathy and its relationship to Alzheimer's disease
Dietmar Rudolf Thal et al.
ACTA NEUROPATHOLOGICA (2008)
Cholesterol is a determinant of the structures of discoidal high density lipoproteins formed by the solubilization of phospholipid membranes by apolipoprotein A-I
John B. Massey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system
Robert D. Bell et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis -: A randomized controlled trial
Jean-Claude Tardif et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles
Thomas G. Beach et al.
ACTA NEUROPATHOLOGICA (2007)
High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I
D Seetharam et al.
CIRCULATION RESEARCH (2006)
Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice
R Koldamova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Deletion of Abca1 increases Aβ deposition in the PDAPP transgenic mouse model of Alzheimer disease
SE Wahrle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
APP23 mice as a model of Alzheimer's disease: An example of a transgenic approach to modeling a CNS disorder
D Van Dam et al.
CNS SPECTRUMS (2005)
Essential requirement of apolipoprotein J (clusterin) signaling for IκB expression and regulation of NF-κB activity
G Santilli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Involvement of transcription factors in plasma HDL protection against TNF-α-induced vascular cell adhesion molecule-1 expression
SH Park et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Clusterin, a binding protein with a molten globule-like region
RW Bailey et al.
BIOCHEMISTRY (2001)
Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysophingolipids
JR Nofer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
